Paediatrics and Child Health, University College Cork, Cork, Ireland.
INFANT Centre, University College Cork, Cork, Ireland.
Allergy. 2022 Sep;77(9):2760-2769. doi: 10.1111/all.15312. Epub 2022 Apr 22.
Cow's milk protein allergy (CMPA) is one of the most common food allergies in infancy. Most infants with CMPA tolerate baked milk from diagnosis and gradually acquire increased tolerance. Nevertheless, parents often display significant anxiety about this condition and a corresponding reluctance to progress with home introduction of dairy due to concerns about possible allergic reactions.
To evaluate the impact on gradual home introduction of foods containing cows' milk after a supervised, single low-dose exposure to whole milk at time of diagnosis.
Infants less than 12 months old referred with suspected IgE-mediated cow's milk allergy were recruited to an open-label randomized, controlled trial of intervention-a single dose of fresh cow's milk, using the validated dose of milk that would elicit reactions in 5% of CMPA subjects-the ED - vs routine care. Both groups implemented graded exposure to CM (using the 12 step MAP Milk Tolerance Induction Ladder), at home. Parents completed food allergy quality of life questionnaires and State and Trait Anxiety Inventories (STAI). Main outcome measures were milk ladder position at 6 months and 12 months post-randomization.
Sixty patients were recruited, 57 (95%) were followed to 6 months. By 6 months, 27/37 (73%) intervention subjects had reached step 6 or above on the milk ladder compared to 10/20 (50%) control subjects (p = .048). By 6 months, 11/37 (30%) intervention subjects had reached step 12 (i.e. drinking unheated cow's milk) compared to 2/20 (10%) of the controls (p = .049). Twelve months post-randomization, 31/36(86%) of the intervention group and 15/19(79%) of the control group were on step 6 or above. However, 24/37 (65%) of the intervention group were at step 12 compared to 7/20 (35%) of the control group (p = .03). Maternal STAIs were significantly associated with their infants' progress on the milk ladder and with changes in skin prick test and spIgE levels at 6 and 12 months.
This study demonstrates the safety and effectiveness of introduction of baked milk implemented immediately after diagnosis of cows' milk allergy in a very young cohort. A supervised single dose of milk at the ED significantly accelerates this further, probably by giving parents the confidence to proceed. Maternal anxiety generally reflects infants' progress towards completion of the milk ladder, but pre-existing high levels of maternal anxiety are associated with poorer progress.
牛奶蛋白过敏(CMPA)是婴儿最常见的食物过敏之一。大多数 CMPA 婴儿在确诊后可耐受烘焙牛奶,并逐渐获得更高的耐受性。然而,由于担心可能出现过敏反应,父母通常对这种情况感到明显焦虑,并相应地不愿意在家中引入乳制品。
评估在诊断时进行单次低剂量全牛奶暴露后的监督下,逐渐在家中引入含牛奶食物对牛奶过敏的影响。
招募了小于 12 个月龄、疑似 IgE 介导的牛奶过敏的婴儿,参加一项开放标签随机对照试验,干预措施为单次新鲜牛奶剂量,使用可诱发 5% CMPA 患者出现反应的验证剂量(ED)-与常规护理。两组均在家中使用经过验证的 12 步 MAP 牛奶耐受性诱导阶梯进行 CM(牛奶)逐渐暴露。父母完成食物过敏生活质量问卷和状态和特质焦虑量表(STAI)。主要结局指标为随机分组后 6 个月和 12 个月时的牛奶阶梯位置。
共招募了 60 名患者,其中 57 名(95%)随访至 6 个月。6 个月时,37 名干预组中有 27/37(73%)达到牛奶阶梯的第 6 步或更高,而 20 名对照组中有 10/20(50%)(p=0.048)。6 个月时,37 名干预组中有 11/37(30%)达到第 12 步(即饮用未加热的牛奶),而对照组中有 2/20(10%)(p=0.049)。随机分组后 12 个月,干预组有 31/36(86%)和对照组有 15/19(79%)达到第 6 步或更高。然而,干预组有 24/37(65%)达到第 12 步,而对照组有 7/20(35%)(p=0.03)。母亲的 STAI 与婴儿在牛奶阶梯上的进展以及 6 个月和 12 个月时皮肤点刺试验和特异性 IgE 水平的变化显著相关。
本研究表明,在非常年幼的队列中,在确诊牛奶过敏后立即进行烘焙牛奶的引入是安全有效的。在 ED 处进行单次牛奶剂量可显著加速这一进程,可能是因为这给了父母继续前进的信心。母亲的焦虑通常反映了婴儿在完成牛奶阶梯方面的进展,但预先存在的高水平母亲焦虑与较差的进展相关。